Syngene International P/B Ratio
Syngene International P/B ratio. Syngene International (SYNGENE) P/B ratio is 3.67 (High), book value per share ₹120.07 vs Healthcare average P/B of -0.3 — High - Premium to book value, growth expectations or asset-light model. Read SYNGENE dividend growth for the complete payout history and dividend yield track record.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
SYNGENE P/B Ratio — Valuation Insights & Book Value Analysis
Syngene International price-to-book ratio interpretation, valuation status and historical context — current P/B 3.67 (High). Browse SYNGENE cash flow statement for revenue, profit, balance sheet and cash flow data.
- Stock appears overvalued with PB of 3.67, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 43.0% below historical average
- Trading at premium to sector average PB of -0.3
Syngene International P/B Ratio Historical Trend
SYNGENE annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see SYNGENE share price screener.
SYNGENE Historical P/B Ratio — Book Value Per Share & Year-End Price
Syngene International annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 3.64 | ₹120.07 | ₹437.35 | ₹4,839 | High |
| 2025 | 5.55 | ₹117.3 | ₹651.00 | ₹4,727 | High |
| 2024 | 8.1 | ₹105.92 | ₹858.45 | ₹4,258 | High |
| 2023 | 7.77 | ₹90.22 | ₹701.45 | ₹3,618 | High |
| 2022 | 7.12 | ₹82.24 | ₹585.55 | ₹3,298 | High |
SYNGENE vs Healthcare Peers — P/B Ratio Comparison
Syngene International P/B 3.67 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Chennai Meenakshi Multis… | CMMHOSP | -7.62 | ₹27 | Low |
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹39 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.75 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹43 | Low |